Cargando…
Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada
BACKGROUND: This study examines individual-level factors associated with avoiding two important health services for people who use drugs—medications for treatment of opioid use disorder and syringe service programs—during the first year of the COVID-19 pandemic. METHODS: Data come from two subsample...
Autores principales: | Feder, Kenneth A., Choi, JinCheol, Schluth, Catherine G., Hayashi, Kanna, DeBeck, Kora, Milloy, Michael-John, Kirk, Gregory D., Mehta, Shruti H., Kipke, Michele, Moore, Richard D., Baum, Marianna K., Shoptaw, Steven, Gorbach, Pamina M., Mustanski, Brian, Javanbakht, Marjan, Siminski, Suzanne, Genberg, Becky L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225925/ https://www.ncbi.nlm.nih.gov/pubmed/35779987 http://dx.doi.org/10.1016/j.drugalcdep.2022.109544 |
Ejemplares similares
-
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada()
por: Moallef, Soroush, et al.
Publicado: (2022) -
Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV
por: Gorbach, Pamina M., et al.
Publicado: (2022) -
Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO consortium
por: Javanbakht, Marjan, et al.
Publicado: (2023) -
Prevalence and correlates of stocking up on drugs during the COVID-19 pandemic: Data from the C3PNO Consortium
por: King, L., et al.
Publicado: (2022) -
HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: A multi-cohort study
por: Baum, Marianna K., et al.
Publicado: (2022)